Distinguishing Alzheimer’s Disease Patients and Biochemical Phenotype Analysis Using a Novel Serum Profiling Platform: Potential Involvement of the VWF/ADAMTS13 Axis

It is important to develop minimally invasive biomarker platforms to help in the identification and monitoring of patients with Alzheimer’s disease (AD). Assisting in the understanding of biochemical mechanisms as well as identifying potential novel biomarkers and therapeutic targets would be an add...

Descripción completa

Detalles Bibliográficos
Autores principales: Hanas, Jay S., Hocker, James R. S., Vannarath, Christian A., Lerner, Megan R., Blair, Scott G., Lightfoot, Stan A., Hanas, Rushie J., Couch, James R., Hershey, Linda A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8145311/
https://www.ncbi.nlm.nih.gov/pubmed/33946285
http://dx.doi.org/10.3390/brainsci11050583

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8145311/
https://www.ncbi.nlm.nih.gov/pubmed/33946285
http://dx.doi.org/10.3390/brainsci11050583

Ejemplares similares